Emily Ferris and Alex Arbuckle describe how using mint Lesion™ has enhanced their clinical trial operations, enabling “a more cooperative approach between [their] radiologists and oncologists” while simultaneously saving time and reducing costs.
Faced with a multitude of clinical trial site reads each day, Ms. Ferris and Mr. Arbuckle explain how they benefit from a more efficient workflow by using a dedicated software platform which provides a comprehensive and compliant response assessment and supports them in maintaining oversight of clinical trial imaging analysis design.
Ms. Ferris is a Lead Image Analyst and Mr. Arbuckle is a Clinical Research Imaging Core Manager at the University of Wisconsin Carbone Cancer Center.
Enhancing flexibility and communication while saving costs and time in clinical trials
Related Resources
Related Resources
Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™
Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…
New Technique Speeds Up Whole-Body MRI for Children Without Sacrificing Image Quality, Study Finds
As we mark Childhood Cancer Awareness Month, we would like to highlight the progress achieved in the realm of cancer diagnostics. A recent study led…
Study Discovers Overdiagnosis of Progressive Cancer in Routine Clinical Evaluations
A recent retrospective study led by Dr. Marilyn J. Siegel and her team at the Washington University School of Medicine in St. Louis has shed light on…